Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : American Presidential Politics and foreign affairs -- Ignore unavailable to you. Want to Upgrade?

To: TimF who wrote (36586)	8/27/2009 6:28:29 PM
From: DuckTapeSunroof	Read Replies (1) \| Respond to of 71588

Re: "If the substance is given a new patent as a new substance" An inert filler is an inert filler --- not the active ingredient. Currently patent extensions are allowed (and have been granted) for such froo-frau as changing the inert filler, or changing the color of the capsule. From a societal point-of-view, I regard that as a serious flaw in our system of patenting... (but from the point-of-view of the corporation only wanting to bar competition from his market a while longer, and milk it's cash cow for a couple more Millions or Billions in domestic sales, that's considered a 'good feature' in our system. :-)